Author

Lei Wu

Institutions: Chinese PLA General Hospital, First Affiliated Hospital of Chinese PLA General Hospital, Chinese People's Liberation Army

Observed institutions: Chinese PLA General Hospital, First Affiliated Hospital of Chinese PLA General Hospital, Chinese People's Liberation Army

ORCID: 0000-0002-5146-2630

Observed ORCID: 0000-0002-5146-2630

OpenAlex ID: A5130305347

Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial

2026 · Lei Wu, Liangliang Gu, et al. · Nature Medicine · 1

Safety and Efficacy of Obinutuzumab β (MIL62), a Novel Glycoengineered Type II Anti-CD20 Monoclonal Antibody, in Patients with Neuromyelitis Optica Spectrum Disorder: A Multicenter, Single-Arm, Phase Ib Clinical Trial

2026 · Lei Wu, Min Wei, et al. · Neurology and Therapy · 1

Worsening Spastic Paraparesis After Lumbar Puncture in a Young Adult

2026 · Hui Sun, Lei Wu, et al. · JAMA Neurology

A real-world study on the long-term efficacy of rituximab in relapsing myelin oligodendrocyte glycoprotein antibody-associated disease

2026 · Cairui Yu, Xiaoguang Chen, et al. · Multiple Sclerosis and Related Disorders

Primary Central Nervous System Lymphoma With the First Onset in the Spinal Cord: Report of One Case and Literature Review.

2026 · Li Zhang, Zi-Wang Han, et al. · PubMed

Works count: 5

Citation count: 2

H-index: 1

I10-index: